Cohance Lifesciences Limited — Updates, 18-09-2025: General Updates
18-09-2025 | 07:26 pm
18-09-2025 | 07:26 pm
Cohance Lifesciences' promoter, Jusmiral Holdings, sold 3.41 Cr shares for ₹3,093.81 Cr. Proceeds are primarily for debt repayment. This reduces the promoter's stake from 33.08% to 24.15%.
No comments yet. Be the first to comment!
